Oral Class I and III antiarrhythmic drugs for maintaining sinus rhythm after catheter ablation of atrial fibrillation-Reference-Cited by-同舟云学术

Oral Class I and III antiarrhythmic drugs for maintaining sinus rhythm after catheter ablation of atrial fibrillation

Published:2020-10-26 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Warraich Mazhar¹,Peter Christina²,Ahmad Mahmood³,Sheikh Shazaib⁴,Abraham George R⁵,Sahibzada Muhammad Salman⁶,Baral Ranu⁷,Muzaffar Adnan⁸,Tomson Joseph⁵,Lambiase Pier⁹,Captur Gabriella¹⁰¹¹,Banerjee Amitava¹²,Providencia Rui¹³

Affiliation:

1. Department of Internal Medicine; The Royal Wolverhampton Hospitals NHS Trust; Wolverhampton UK

2. Department of Cardiology; Addenbrookes Hospital (Cambridge University Hospitals); Cambridge UK

3. Cardiology Department; Royal Free Hospital, Royal Free London NHS Foundation Trust; London UK

4. Department of Anaesthesia; St Helier Hospital; London UK

5. Department of Cardiology; Royal Free Hospital; London UK

6. Calderdale Royal Hospital; Halifax UK

7. University of East Anglia; Norwich UK

8. Scunthrope General Hospital; Scunthorpe UK

9. Centre for Cardiology in the Young; The Heart Hospital, University College London Hospitals; London UK

10. Royal Free Hospital; London UK

11. MRC Unit of Lifelong Health and Ageing; University College London; London UK

12. Institute of Health Informatics Research; University College London; London UK

13. Barts Heart Centre; St Bartholomew's Hospital, Barts Health NHS Trust; London UK

Publisher

Wiley

Subject

Pharmacology (medical)

Reference26 articles.

1. Prevalence and treatment of atrial fibrillation in UK general practice from 2000 to 2016;Adderley;Heart,2019

2. Atrial fibrillation prevention: an appraisal of current evidence;Boriani;Heart,2018

3. The levels of evidence and their role in evidence-based medicine;Burns;Plastic Reconstructive Surgery,2011

4. HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: executive summary;Calkins;Journal of Arrhythmia,2017

5. Veritas Health Innovation Covidence